A must-read for medication use! Pemetinib side effects
PemigatinibIndicated for the treatment of fibroblast growth factor receptor2(fgfr 2) Adults with previously treated unresectable locally advanced or metastatic cholangiocarcinoma with fusion or other rearrangement. Pemetinib/Pemetinibis suitable for the treatment of patients with fibroblast growth factor receptor1(FGF Adults with relapsed or refractory myeloid /lymphoid neoplasms (MLNs) rearranged with R1.

Pemetinib/Common side effects of pemetinib includeincreased phosphate (94%), decreased phosphate (68%), Hyperphosphatemia (60%), Alopecia (49%), Diarrhea (47 %), Nail toxicity (43%), Aspartate aminotransferase/Elevated alanine aminotransferase (43%< span>), Increased calcium content (43%), Decreased hemoglobin (43%), Fatigue (42%< span>), Increased alkaline phosphatase (41%), Increased creatinine (41%), Nausea (40% ), Geustosis (40%), Reduced sodium (39%), Increased blood sugar (36% pan>), lymphopenia (36%), constipation (35%), stomatitis (35%
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)